Several discussions acknowledge the article's comprehensive review of DPI types and patient preferences, with mentions of how improper use and education are key issues. For example, some comments highlight the environmental benefits of DPIs, and others reference the importance of patient understanding, illustrating a balanced engagement with both technical and practical aspects of inhaler use.
AgreementModerate agreement
Most discussions acknowledge the article's relevance and generally align with its focus on technical and patient-centered aspects of DPIs.
InterestModerate interest
Participants show moderate interest, referencing the article's importance for asthma and COPD management and mentioning related debates.
EngagementModerate engagement
Comments include references to environmental impacts, clinical practice, and discussions of method advantages, indicating a moderate level of engagement.
ImpactModerate impact
These discussions highlight the article’s influence on considerations of inhaler selection, environmental impact, and clinical strategies.
Abstract in brief
This article explains the different types of dry powder inhalers (DPIs) used for asthma and COPD, highlighting how their various operating principles can be confusing for both healthcare providers and patients.
It notes that most patients can generate the necessary inspiratory flow for high-resistance DPIs, but emphasizes that improper use and poor adherence are common issues that require ongoing patient education and monitoring.
The purpose of the paper is to review how DPIs work and to identify key features to consider when selecting the most suitable inhaler for each patient, with support from Orion Pharma.
Commentary article discusses dry powder inhalers and key technical and patient preference attributes: https://t.co/xDhj1Sd9C5 #asthma #COPD #inhaler https://t.co/Rta83IZ0a9
Sep 2, 2019 · 1 like · 1 share · 1,192 followersView post →
CR
COPD_research
@COPD_research · X
RT @jlizquierdoa: Una reciente revisión sobre este tema. Commentary article discusses dry powder inhalers and key technical and patient pre…
Oct 25, 2019 · 1 share · 3,930 followersView post →
WC
Will Carroll
@heretolearnkids · X
@DrSeanMon @marinasoltan_ @asthmauk @AsthmaIreland Sort of Sean. Although its not straightforward DPI = low global warming impact. Plastic is an issue, and kids under 7 need pMDI and spacer. The full. Paper gives a better overview. Mentioned in this https://t.co/OkWfvUPAoL
Thinking aloud about Tari H's talk. Maybe we should at least mention that DPIs have a lower environmental impact on climate change. Recently reviewed here (open access). COI disclaimer, funding received from Orion (by me). #ERSCongress #ers2019 @gsk https://t.co/OkWfvUPAoL
This video explains how dry powder inhalers work and discusses key technical features and patient preferences to optimize asthma and COPD treatment, emphasizing proper use and adherence for effective disease management.
RT @jlizquierdoa: Una reciente revisión sobre este tema. Commentary article discusses dry powder inhalers and key technical and patient pre…
Oct 25, 2019 · 1 share · 3,930 followersView post →
JI
Jose Luis Izquierdo
@jlizquierdoa · X
Una reciente revisión sobre este tema. Commentary article discusses dry powder inhalers and key technical and patient preference attributes: https://t.co/stH1Nng8BR #asthma #COPD #inhaler https://t.co/epHYopMQsP
@DrSeanMon @marinasoltan_ @asthmauk @AsthmaIreland Sort of Sean. Although its not straightforward DPI = low global warming impact. Plastic is an issue, and kids under 7 need pMDI and spacer. The full. Paper gives a better overview. Mentioned in this https://t.co/OkWfvUPAoL
Thinking aloud about Tari H's talk. Maybe we should at least mention that DPIs have a lower environmental impact on climate change. Recently reviewed here (open access). COI disclaimer, funding received from Orion (by me). #ERSCongress #ers2019 @gsk https://t.co/OkWfvUPAoL
Commentary article discusses dry powder inhalers and key technical and patient preference attributes: https://t.co/xDhj1Sd9C5 #asthma #COPD #inhaler https://t.co/Rta83IZ0a9
Sep 2, 2019 · 1 like · 1 share · 1,192 followersView post →
N
Journal of Controlled Release | PDF
News
... 10.1007/s12325- [38] P. Sehr, K. Zumbach, M. Pawlita, A generic capture ELISA for recombinant proteins 019-01066-6. fused to glutathione S-transferase ...
AT
CR
WC
JI